94 related articles for article (PubMed ID: 24512657)
1. The second life of antibodies.
Navolotskaya EV
Biochemistry (Mosc); 2014 Jan; 79(1):1-7. PubMed ID: 24512657
[TBL] [Abstract][Full Text] [Related]
2. [Interaction of synthetic decapeptide SLTCLVKGFY with human T lymphocytes].
Navolotskaia EV; Malkova NV; Lepikhova TN; Krasnova SB; Zargarova TA; Zav'ialov VP; Lipkin VM
Bioorg Khim; 2001; 27(5):359-63. PubMed ID: 11641910
[TBL] [Abstract][Full Text] [Related]
3. Detection of nonopioid β-endorphin receptor in the rat myocardium.
Nekrasova YN; Zolotarev YA; Navolotskaya EV
J Pept Sci; 2012 Feb; 18(2):83-7. PubMed ID: 22052815
[TBL] [Abstract][Full Text] [Related]
4. Binding of synthetic fragments of beta-endorphin to nonopioid beta-endorphin receptor.
Navolotskaya EV; Kovalitskaya YA; Zolotarev YA; Sadovnikov VB
J Pept Sci; 2008 Oct; 14(10):1121-8. PubMed ID: 18618430
[TBL] [Abstract][Full Text] [Related]
5. Synthetic beta-endorphin-like peptide immunorphin binds to non-opioid receptors for beta-endorphin on T lymphocytes.
Navolotskaya EV; Malkova NV; Zargarova TA; Lepikhova TN; Zav'yalov VP; Lipkin VM
Peptides; 2001 Dec; 22(12):2009-13. PubMed ID: 11786184
[TBL] [Abstract][Full Text] [Related]
6. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic peptide immunorphin as an instrument for studying nonopioid beta-endorphin receptor].
Kovalitskaia IuA; Navolotskaia EV
Bioorg Khim; 2010; 36(1):47-55. PubMed ID: 20386578
[TBL] [Abstract][Full Text] [Related]
8. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-endorphin and beta-endorphin-like peptide immunorphin on the growth of human leukemic cells in vitro.
Malkova NV; Krasnova SB; Navolotskaya EV; Zargarova TA; Prasolov VS
Russ J Immunol; 2002 Oct; 7(3):239-44. PubMed ID: 12674933
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthetic beta-endorphin-like peptide immunorphin on human T lymphocytes.
Navolotskaya EV; Malkova NV; Zargarova TA; Lepikhova TN; Krasnova SB; Lipkin VM
Biochemistry (Mosc); 2002 Mar; 67(3):357-63. PubMed ID: 11970735
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptide SLTCLVKGFY competes with beta-endorphin for naloxone-insensitive binding sites on rat brain membranes.
Navolotskaya EV; Zargarova TA; Malkova NV; Krasnova SB; Zav'yalov VP; Lipkin VM
Peptides; 2002 Jun; 23(6):1115-9. PubMed ID: 12126739
[TBL] [Abstract][Full Text] [Related]
12. beta-Endorphin-like peptide SLTCLVKGFY is a selective agonist of nonopioid beta-endorphin receptor.
Navolotskaya EV; Zargarova TA; Malkova NV; Krasnova SB; Zav'yalov VP; Lipkin VM
Biochem Biophys Res Commun; 2002 Apr; 292(4):799-804. PubMed ID: 11944884
[TBL] [Abstract][Full Text] [Related]
13. Receptor-binding properties of the peptides corresponding to the beta-endorphin-like sequence of human immunoglobulin G.
Zav'yalov VP; Zaitseva OR; Navolotskaya EV; Abramov VM; Volodina EYu ; Mitin YV
Immunol Lett; 1996 Jan; 49(1-2):21-6. PubMed ID: 8964604
[TBL] [Abstract][Full Text] [Related]
14. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII.
Goldsmith EB; Erickson BW; Thompson NL
Biochemistry; 1997 Jan; 36(4):952-9. PubMed ID: 9020795
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.
Lukas TJ; Muñoz H; Erickson BW
J Immunol; 1981 Dec; 127(6):2555-60. PubMed ID: 7299136
[TBL] [Abstract][Full Text] [Related]
17. [Effects and mechanism of action of synthetic peptide octarphin].
Nekrasova IuN; Sadovnikov VB; Zolotarev IuA; Navolotskaia EV
Bioorg Khim; 2010; 36(5):638-45. PubMed ID: 21063450
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the murine immune response to human IgG by complexing with monoclonal antibodies. I. Antibody responses to determinants on the constant region of light chains and gamma chains.
Ling NR; Elliott D; Lowe J
Immunology; 1987 Sep; 62(1):1-6. PubMed ID: 2443445
[TBL] [Abstract][Full Text] [Related]
19. Folding and oxidation of the antibody domain C(H)3.
Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
[TBL] [Abstract][Full Text] [Related]
20. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Tao MH; Morrison SL
J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
